SightfileU.S. market data from official filings
Companies › CGEN
COMPUGEN LTD (CGEN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001119774 · EDGAR filings · Updated 2026-07-13
COMPUGEN LTD (CGEN) has reported institutional ownership of 15.0%, with 77 institutional managers holding positions valued at $30.9M per the latest 13F reporting period.
Institutional ownership
15.0%
Institutional managers
77
Reported 13F value
$30.9M
Insider activity
2 trans.
−$24.2K net selling
Latest updates
- 2026-07-13 — Insider transaction reported (Form 4)
- 2026-06-08 — EFFECT filed
- 2026-05-18 — F-3 filed
- 2026-05-18 — Foreign issuer report (6-K) filed
- 2026-04-27 — Insider transaction reported (Form 4)
- 2026-04-27 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, COMPUGEN LTD has 77 institutional holders and institutional ownership of 15.0%.
Insider activity
Insiders reported 2 transactions (0 buys, 1 sells) across 12 reporting insiders, with a net reported value of −$24.2K.
Related companies
CELLECTIS S A (CLLS) · CONNECT BIOPHARMA HLDGS LTD (CNTB) · COYA THERAPEUTICS INC (COYA) · AGENUS INC (AGEN) · LENSAR INC (LNSR) · CAPSOVISION INC (CV)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-13.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-13.